Alnylam Pharmaceuticals, Inc. (ALNY)

224.03 -3.25 (-1.43%) USD  |  NASDAQ  |  Oct 23, 16:00
223.90 -0.13 (-0.06%) After-Hours: 20:00
More

Alnylam Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
BridgeBio Pharma, Inc. --
Pfizer Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade